3Schmidt KR,Van Os J,Steinbusch H,et al.Gene regulation by hypoxia and the neurodevelopmental orgin of schizophrenia[J].Schizophrenia Research,2006,84(2-3):253-271.
6PORTER, M.E.Clusters and the new economics of competition.Harward Business Review, Nov/Dec98,1998, 76(6):77- 91.
7Ho BC,Andreasen NC,Dawson JD,et al.Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia[J].Psychiatry,2007,164:1890-1899.
8Kunihiro Kawashima,Masashi Ikeda,Taro Kishi.BDNF is not associated with schizophrenia:Data from a Japanese population study and meta-analysis[J] Schizophrenia Research,2009,112:72-79.
2Lewin GR, Barde YA. Physiology of the neuortorphins[ J ], Annu Rev Neurosc, 1996,19:289-317.
3Rizos EN, Rontos 1, l,askos E, et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia [ J ]. Progress in neuropsychopharmacology & Biological Psychiatry,2008,32 : 1308- 1311.
4Peter FB, Anilkumar P, Denise E, et al. Brain derived neurotropite factor in first-episode psychosis[ J ]. Schizophrenia Research ,2007. 91:1-5.
5Karege F, Schwahl M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets [ J ]. Neurosci. Lett ,2002,328:261-264.
6Durany N,Miehel T,Zochling R,et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Sehizophr Res [J].2001,52:79-86.
7Toyooka K, Asama K,Watanabe Y,et al. Decreased level of brainderived neurotrophic factoring serum of ehronic schizophrenic patients[ J]. Psychiat~ Res ,2002,110:249-257.
8Szeszko PR,Lipsky R, Mentschel C,et al. Brain-derived neurotrophic factor va166met polymorphism and volume of the hippocampal formation[ J]. Mol Psychiatry,2005,10:631-636.
9Voge IM,Busse S,Freyberger HJ,et al. DopamineD3 receptor and schizophrenia: a widened scope for the immune hypothesis [ J ]. Medical hypotheses ,2006,67:354-355.
10Shalev I, Lerer E, Israel S, et al. BDNF Va166Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions[ J ]. Psychoneuroendocrinology, 2009,34 : 382 -388.
7FITZGERALD P B, SRITHARAN A, BENITEZ J, et al. A prelir- runary fMRI study of the effects on cortical activatioa of the treat- ment of refractory auditory hallucinations with Rtms [ J ]. Psychiatry Res, 2007, 155(1): 83-88.
8SHERGILL S S, MURRAY R M, McGUIRE P K. Auditory hallu- cination : a review of psychological treatments [ J ]. Sehizophr Res, 1998, 32(3) : 137 -150.
9LEE S H, KIM W, CHUNG Y C, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizo- phrenia who are having treatment - refractory auditory hallucina- tions[J]. Neurosci Lett, 2005, 376(3) : 177 - 181.
10MILLER M B, TOSCHI N, KRESSE A E, et al. Long - term re- petitive transeranial magnetic stimulation increases the expression of brain - derived neurotrophic factor and cholecystokinin mRNA, but not ncuropeptide tyrosine mRNA in specific areas of rat brain [ J ]. Neuropsychopharmacology, 2000, 23 (2) : 205 - 215.
